Ibere Pharmaceuticals (IBER) Financial Statements (2024 and earlier)

Company Profile

Business Address 2005 MARKET STREET, SUITE 2030
PHILADELPHIA, PA 19103
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 677 - Blank Checks (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments93,041134,755458,388680,415855,8081,217,248
Cash and cash equivalents93,041134,755458,388680,415855,8081,217,248
Prepaid expense182,770192,600235,000291,465350,185409,300
Total current assets:275,811327,355693,388971,8801,205,9931,626,548
Noncurrent Assets
Asset, held-in-trust138,108,723138,020,343138,016,940138,012,119138,008,715138,004,575
Total noncurrent assets:138,108,723138,020,343138,016,940138,012,119138,008,715138,004,575
TOTAL ASSETS:138,384,534138,347,698138,710,328138,983,999139,214,708139,631,123
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Debt  1,500,0001,500,0001,500,0001,500,000 
Due to related parties158,866    5,959
Other undisclosed current liabilities239,142(1,190,975)(1,127,556)(1,209,478)(1,290,864)389,975
Total current liabilities:398,008309,025372,444290,522209,136395,934
Noncurrent Liabilities
Other undisclosed noncurrent liabilities5,768,8007,294,35011,166,90011,871,00013,914,30014,031,650
Total noncurrent liabilities:5,768,8007,294,35011,166,90011,871,00013,914,30014,031,650
Total liabilities:6,166,8087,603,37511,539,34412,161,52214,123,43614,427,584
Temporary equity, carrying amount     138,000,000138,000,000
Equity
Equity, attributable to parent, including:(5,890,997)(7,276,020)(10,845,956)(11,177,523)(12,908,728)(12,796,461)
Accumulated deficit(5,891,342)(7,276,365)(10,846,301)(11,177,868)(12,909,073)(12,796,806)
Other undisclosed equity, attributable to parent345345345345345345
Other undisclosed equity138,108,723138,020,343138,016,940138,000,000  
Total equity:132,217,726130,744,323127,170,984126,822,477(12,908,728)(12,796,461)
TOTAL LIABILITIES AND EQUITY:138,384,534138,347,698138,710,328138,983,999139,214,708139,631,123

Income Statement (P&L) (USD)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues
(Net Investment Income)
      176
Gross profit:      176
Operating expenses(140,527)(302,614)(360,414)(315,499)(233,757)(94,478)
Other undisclosed operating loss      (176)
Operating loss:(140,527)(302,614)(360,414)(315,499)(233,757)(94,478)
Nonoperating income (expense)1,613,9303,875,953708,9212,046,704121,490(311,220)
Investment income, nonoperating88,3803,4034,8213,4046,1292,586
Income (loss) from continuing operations:1,473,4033,573,339348,5071,731,205(112,267)(405,698)
Income (loss) before gain (loss) on sale of properties:1,473,4033,573,339348,5071,731,205(112,267)(405,698)
Net income (loss) attributable to parent:1,473,4033,573,339348,5071,731,205(112,267)(405,698)
Preferred stock dividends and other adjustments(88,380)(3,403)(16,940)  (13,377,004)
Other undisclosed net loss available to common stockholders, basic  (7,139,872)    
Net income (loss) available to common stockholders, diluted:1,385,023(3,569,936)331,5671,731,205(112,267)(13,782,702)

Comprehensive Income (USD)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net income (loss):1,473,4033,573,339348,5071,731,205(112,267)(405,698)
Comprehensive income (loss), net of tax, attributable to parent:1,473,4033,573,339348,5071,731,205(112,267)(405,698)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: